Our site uses cookies to make navigation as functional as possible, including "third party" cookies and "profiling cookies" designed to tailor on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here. If you proceed browsing this website, you will be consenting to the use of all cookies.
More info
itaeng

Innovative spirit

For over thirty years Menarini has been making important investments in Research and Development with special attention to innovation: our constant and growing commitment to the research of new drugs and therapeutic indications has consolidated Menarini's role as the partner par excellence in the pharmaceutical and biotechnology fields.

For Menarini innovation means thinking creatively and outside the box. It means seeking new technologies and investing in cutting-edge machinery for developing new and higher quality drugs.

Latest News

22 Jan 2021
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) Awareness Day
23 rd January 2021 marks the second annual BPDCN Awareness Day (#BPDCNday) since it received its ow...
Read More »

Related topics

Menarini Research

Menarini Ricerche is in charge of all the Group's Research and Development activities: from the initial phases of a new project up to drug registration.

The biotechnology centre, Menarini Biotech, and the Menarini Research and Development Centre guarantee the continuous development of target therapies and define new innovative approaches to research.

Main Products In Development

oncology
anti-infective
preclinical
phase i
phase ii
phase iii
registration
post-registration
Tagraxofusp (Elzonris®)
Blastic plasmacytoid dendritic cell neoplasm (FDA)
Blastic plasmacytoid dendritic cell neoplasm (EMA)
Tagraxofusp
Chronic myelomonocytic leukemia, Myelofibrosis
Elacestrant
Breast cancer
Pracinostat
AML/Acute Myeloid Leukemia
SMD/Myelodysplastic Syndrome
men1703
AML/Acute myeloid leukaemia
men1611
Breast Cancer
Colorectal cancer
men1112
AML/Acute myeloid leukaemia
men1309
Solid Tumors
Felezonexor
Solid tumors
SL-901
Solid tumors
SL-1001
Solid tumors
Meropenem/Vaborbactam
cUTI, cIAI, HABP, VABP and Bacteremia
Delafloxacin
ABSSSI/Acute Bacterial Skin and Skin Structure Infections
CABP/Community Acquired Bacterial Pneumonia
Oritavancin
ABSSSI/acute bacterial skin and skin structure infections
ABSSSI/acute bacterial skin and skin structure infections
Find Menarini in the World
Select search criteria.
Country
Facilities

Contact Menarini

Use the search form to find all of the Group's companies, manufacturing sites, research centers and Menarini distributors in the world.

THERAPEUTIC AREAS

Discover all of Menarini's products marketed in Italy. Read More »

DIAGNOSTICS

 

Advanced Technology

READ MORE »

THE MENARINI GROUP

Discover the leading Italian pharmaceutical company in the world. Read More »

MENARINI PILLS OF ART

Concession granted by Italian Ministry for Cultural Heritage and Activities Read more